BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10514448)

  • 1. Cytosine arabinoside lesions are position-specific topoisomerase II poisons and stimulate DNA cleavage mediated by the human type II enzymes.
    Cline SD; Osheroff N
    J Biol Chem; 1999 Oct; 274(42):29740-3. PubMed ID: 10514448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints.
    Kingma PS; Greider CA; Osheroff N
    Biochemistry; 1997 May; 36(20):5934-9. PubMed ID: 9166762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using 3'-bridging phosphorothiolates to isolate the forward DNA cleavage reaction of human topoisomerase IIalpha.
    Deweese JE; Burgin AB; Osheroff N
    Biochemistry; 2008 Apr; 47(13):4129-40. PubMed ID: 18318502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,4-Benzoquinone is a topoisomerase II poison.
    Lindsey RH; Bromberg KD; Felix CA; Osheroff N
    Biochemistry; 2004 Jun; 43(23):7563-74. PubMed ID: 15182198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible role for topoisomerase II in cell death and N-phosphonoacetyl-L-aspartate-resistance frequency and its enhancement by 1-beta-D-arabinofuranosyl cytosine and 5-fluoro-2'-deoxyuridine.
    Goz B; Bastow KF
    Mutat Res; 1997 Aug; 384(2):89-106. PubMed ID: 9298118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage.
    Fortune JM; Osheroff N
    J Biol Chem; 1998 Jul; 273(28):17643-50. PubMed ID: 9651360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase II-mediated DNA cleavage and religation in the absence of base pairing. Abasic lesions as a tool to dissect enzyme mechanism.
    Kingma PS; Osheroff N
    J Biol Chem; 1998 Jul; 273(29):17999-8002. PubMed ID: 9660751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Base excision repair intermediates as topoisomerase II poisons.
    Wilstermann AM; Osheroff N
    J Biol Chem; 2001 Dec; 276(49):46290-6. PubMed ID: 11591703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apurinic sites are position-specific topoisomerase II poisons.
    Kingma PS; Osheroff N
    J Biol Chem; 1997 Jan; 272(2):1148-55. PubMed ID: 8995415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.
    Byl JA; Fortune JM; Burden DA; Nitiss JL; Utsugi T; Yamada Y; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15573-9. PubMed ID: 10569941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
    Vélez-Cruz R; Riggins JN; Daniels JS; Cai H; Guengerich FP; Marnett LJ; Osheroff N
    Biochemistry; 2005 Mar; 44(10):3972-81. PubMed ID: 15751973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topoisomerase II as the target for the anticancer drug TOP-53: mechanistic basis for drug action.
    Byl JA; Cline SD; Utsugi T; Kobunai T; Yamada Y; Osheroff N
    Biochemistry; 2001 Jan; 40(3):712-8. PubMed ID: 11170388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyamine-containing etoposide derivatives as poisons of human type II topoisomerases: Differential effects on topoisomerase IIα and IIβ.
    Oviatt AA; Kuriappan JA; Minniti E; Vann KR; Onuorah P; Minarini A; De Vivo M; Osheroff N
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2961-2968. PubMed ID: 30006062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA cleavage and religation by human topoisomerase II alpha at high temperature.
    Bromberg KD; Osheroff N
    Biochemistry; 2001 Jul; 40(28):8410-8. PubMed ID: 11444988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
    Robinson MJ; Corbett AH; Osheroff N
    Biochemistry; 1993 Apr; 32(14):3638-43. PubMed ID: 8385484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous DNA damage stimulates topoisomerase II-mediated DNA cleavage.
    Kingma PS; Osheroff N
    J Biol Chem; 1997 Mar; 272(11):7488-93. PubMed ID: 9054451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA topoisomerase II cleavage of telomeres in vitro and in vivo.
    Yoon HJ; Choi IY; Kang MR; Kim SS; Muller MT; Spitzner JR; Chung IK
    Biochim Biophys Acta; 1998 Jan; 1395(1):110-20. PubMed ID: 9434158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Olive Metabolites on DNA Cleavage Mediated by Human Type II Topoisomerases.
    Vann KR; Sedgeman CA; Gopas J; Golan-Goldhirsh A; Osheroff N
    Biochemistry; 2015 Jul; 54(29):4531-41. PubMed ID: 26132160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells.
    Bandele OJ; Osheroff N
    Biochemistry; 2008 Nov; 47(45):11900-8. PubMed ID: 18922022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.